Ensign Peak Advisors’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,826
| Closed | -$3.68M | – | 1731 |
|
|
2024
Q1 | $3.68M | Buy |
11,826
+5,795
| +96% | +$1.8M | 0.01% | 723 |
|
|
2023
Q4 | $1.58M | Hold |
6,031
| – | – | ﹤0.01% | 1040 |
|
|
2023
Q3 | $1.18M | Sell |
6,031
-14
| -0.2% | -$2.74K | ﹤0.01% | 1067 |
|
|
2023
Q2 | $1.24M | Hold |
6,045
| – | – | ﹤0.01% | 1091 |
|
|
2023
Q1 | $626K | Hold |
6,045
| – | – | ﹤0.01% | 1565 |
|
|
2022
Q4 | $949K | Buy |
6,045
+4,781
| +378% | +$751K | ﹤0.01% | 1197 |
|
|
2022
Q3 | $317K | Buy |
1,264
+139
| +12% | +$34.9K | ﹤0.01% | 1680 |
|
|
2022
Q2 | $318K | Buy |
1,125
+342
| +44% | +$96.7K | ﹤0.01% | 1657 |
|
|
2022
Q1 | $157K | Hold |
783
| – | – | ﹤0.01% | 1942 |
|
|
2021
Q4 | $171K | Hold |
783
| – | – | ﹤0.01% | 1956 |
|
|
2021
Q3 | $358K | Hold |
783
| – | – | ﹤0.01% | 1685 |
|
|
2021
Q2 | $314K | Hold |
783
| – | – | ﹤0.01% | 1671 |
|
|
2021
Q1 | $454K | Hold |
783
| – | – | ﹤0.01% | 1609 |
|
|
2020
Q4 | $447K | Hold |
783
| – | – | ﹤0.01% | 1622 |
|
|
2020
Q3 | $438K | Buy |
783
+483
| +161% | +$270K | ﹤0.01% | 1564 |
|
|
2020
Q2 | $170K | Buy |
+300
| New | +$170K | ﹤0.01% | 1596 |
|